Mirae Asset Global Etfs Holdings »

Immunovant shares owned by Mirae Asset Global Etfs Holdings

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Mirae Asset Global Etfs Holdings from 13F filings

Historical chart of Mirae Asset Global Etfs Holdings investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Mirae Asset Global Etfs Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $857k 33k 26.00

More positions owned by Mirae Asset Global Etfs Holdings

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Global X Fds X Russell 2000 E
Cameco Corporation (CCJ)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Intuitive Surgical Com New (ISRG)
Alphabet Cap Stk Cl C (GOOG)
Netflix (NFLX)
Costco Wholesale Corporation (COST)
Trane Technologies SHS (TT)

View all positions for Mirae Asset Global Etfs Holdings

Top funds holding Immunovant

FMR
Vanguard Group
BlackRock
Armistice Capital
Deep Track Capital
State Street Corporation
Viking Global Investors
Perceptive Advisors
Alpine Partners VI
Woodline Partners
T. Rowe Price Investment Management
Geode Capital Management
Paradigm Biocapital Advisors
T. Rowe Price Associates
Pictet Asset Management Holding SA

View all funds holding Immunovant